I. Takahashi et al. / Tetrahedron: Asymmetry 23 (2012) 1657–1662
1661
idue by column chromatography (hexane/AcOEt = 1) gave 1b
(64 mg, 63%). The ee (30% ee) of 1b was determined by HPLC anal-
ysis using a CHIRALPACK OD-3 column [25 ꢀ 0.46 cm i.d.; 10% i-
PrOH in hexane; flow rate, 1.5 mL/min; (ꢁ)-1b (major);
tR = 9.8 min, (+)-1b (minor); tR = 19.3 min]. Compound 1b (30%
9.2 min, (+)-1e (minor); tR = 15.7 min]. Compound 1e (55% ee):
white solid; ½a 2D5
ꢂ
¼ ꢁ35:1 (c 0.42, CHCl3); mp 174–177 °C; 1H
NMR (400 MHz, CDCl3, TMS) d = 8.51 (1H, dd, J = 1.4, 7.8 Hz),
7.45–7.50 (2H, m), 7.35–7.39 (2H, m), 7.24 (1H, dt, J = 1.8,
8.2 Hz), 7.09–7.13 (3H, m), 6.98 (2H, d, J = 8.2 Hz), 6.75 (1H, d,
J = 8.2 Hz), 6,46 (1H, s), 2.26 (3H, s), 0.97 (9H, s); 13C NMR
(100 MHz, CDCl3, TMS) d = 178.1, 154.4, 147.5, 143.7, 138.8,
135.4, 133.0, 132.6, 131.8, 131.3, 129.8, 129.5, 128.4, 126.6,
126.2, 125.9, 123.6, 118.7, 113.1, 36.3, 31.5, 21.1; IR (neat)
1621 cmꢁ1; MS (ESI, m/z) 368 (MH+); HRMS (ESI). Calcd for
ee): white solid; ½a D25
¼ ꢁ29:9 (c 0.40, CHCl3); mp 228–230 °C;
ꢂ
1H NMR (400 MHz, CDCl3, TMS) d = 8.52 (1H, dd, J = 1.4, 7.8 Hz),
7.46 (1H, ddd, J = 1.8, 6.9, 8.7 Hz), 7.28–7.39 (4H, m), 7.16–7.25
(6H, m), 6.79 (1H, d, J = 8.7 Hz), 6,50 (1H, s), 2.46 (1H, sept,
J = 6.9 Hz), 0.84 (3H, d, J = 6.9 Hz), 0.78 (3H, d, J = 6.9 Hz); 13C
NMR (100 MHz, CDCl3, TMS) d = 178.0, 154.1, 146.8, 142.7, 136.2,
135.1, 131.7, 130.8, 130.1, 129.5, 128.8, 127.65, 127.56, 126.3,
126.2, 126.1, 123.8, 118.3, 112.6, 27.7, 24.9, 22.0; IR (neat)
1625 cmꢁ1; MS (ESI, m/z) 340 (MH+); Anal. Calcd for C24H21NO:
C, 84.92; H, 6.24; N, 4.13. Found: C, 84.93; H, 6.31; N, 4.03.
C
26H26NO (MH+) 368.2014. Found: 368.2006.
4.3.6. 1-(2-(tert-Butyl)phenyl)-2-(4-chlorophenyl)quinolin-
4(1H)-one 1f
Compound 1f was prepared from 2f (96 mg, 0.3 mmol) and
ortho-tert-butylaniline 3a (90 mg, 0.6 mmol) in accordance with
the general procedure for the synthesis of 1. Purification of the res-
idue by column chromatography (hexane/AcOEt = 1) gave 1f
(36 mg, 31%). The ee (66% ee) of 1f was determined by HPLC anal-
ysis using a CHIRALPACK OD-3 column [25 ꢀ 0.46 cm i.d.; 10%
i-PrOH in hexane; flow rate, 1.5 mL/min; (ꢁ)-1f (major);
tR = 9.8 min, (+)-1f (minor); tR = 26.2 min]. Compound 1f (66%
4.3.3. 1-(2,5-(Di-tert-butyl)phenyl)-2-phenylquinolin-4(1H)-one
1c
Compound 1c was prepared from 2a (86 mg, 0.3 mmol) and 2,
5-di-tert-butylaniline 3c (74 mg, 0.36 mmol) in accordance with
the general procedure for the synthesis of 1. Purification of the res-
idue by column chromatography (hexane/AcOEt = 1) gave 1c
(33 mg, 27%). The ee (21% ee) of 1c was determined by HPLC
analysis using a CHIRALPACK OD-3 column [25 ꢀ 0.46 cm i.d.;
10% i-PrOH in hexane; flow rate, 1.0 mL/min; (+)-1c (minor);
tR = 6.8 min, (ꢁ)-1c (major); tR = 9.1 min]. Compound 1c (21% ee):
ee): white solid; ½a D25
¼ ꢁ38:3 (c 0.41, CHCl3); mp 196–198 °C;
ꢂ
1H NMR (400 MHz, CDCl3, TMS) d = 8.49 (1H, dd, J = 1.4, 7.8 Hz),
7.46–7.52 (2H, m), 7.34–7.40 (2H, m), 7.25 (1H, dt, J = 2.7,
7.8 Hz), 7.16–7.17 (4H, m), 7.10 (1H, dd, J = 1.4, 7.8 Hz), 6.75 (1H,
d, J = 8.7 Hz), 6,41 (1H, s), 0.97 (9H, s); 13C NMR (100 MHz, CDCl3,
TMS) d = 178.0, 152.9, 147.6, 143.6, 135.1, 135.0, 134.0, 132.9,
132.0, 131.5, 131.2, 129.8, 128.0, 126.8, 126.3, 126.0, 123.8,
118.7, 113.2, 36.3, 31.6; IR (neat) 1622 cmꢁ1; MS (ESI, m/z) 388
(MH+); HRMS (ESI). Calcd for C25H23ClNO (MH+) 388.1468. Found:
388.1458.
white solid; ½a 2D5
ꢂ
¼ ꢁ14:9 (c 0.40, CHCl3); mp 216–218 °C; 1H
NMR (400 MHz, CDCl3, TMS) d = 8.52 (1H, dd, J = 1.4, 7.8 Hz), 7.50
(1H, ddd, J = 1.4, 7.3, 8.7 Hz), 7.36–7.40 (2H, m), 7.32 (1H, dd,
J = 1.8, 8.7 Hz), 7.14–7.23 (5H, m), 7.03 (1H, d, J = 1.8 Hz), 6.82
(1H, d, J = 8.7 Hz), 6,49 (1H, s), 1.25 (9H, m), 0.98 (9H, s); 13C
NMR (100 MHz, CDCl3, TMS) d = 178.1, 154.4, 149.8, 144.2, 143.7,
135.6, 134.7, 131.9, 130.8, 129.9, 129.8, 128.7, 127.6, 126.4,
126.3, 125.9, 123.6, 118.8, 113.0, 35.8, 34.1, 31.5, 30,9; IR (neat)
1623 cmꢁ1; MS (ESI, m/z) 410 (MH+); HRMS (ESI). Calcd for
4.3.7. (S)-1-(2-(tert-Butyl)phenyl)-2-(4-nitrophenyl)quinolin-
4(1H)-one 1g
C
29H32NO (MH+) 410.2484. Found: 410.2481.
Compound 1g was prepared from 2g (70 mg, 0.3 mmol) and
ortho-tert-butylaniline 3a (90 mg, 0.6 mmol) in accordance with
the general procedure for the synthesis of 1. Purification of the res-
idue by column chromatography (hexane/AcOEt = 1) gave 1g
(41 mg, 34%). The ee (72% ee) of 1g was determined by HPLC anal-
ysis using a CHIRALPACK OD-3 column [25 ꢀ 0.46 cm i.d.; 50% i-
PrOH in hexane; flow rate, 1.0 mL/min; (ꢁ)-1g (major);
tR = 8.8 min, (+)-1g (minor); tR = 17.1 min]. Compound 1g (72%
4.3.4. 1-(2-(tert-Butyl)phenyl)-2-(4-methoxyphenyl)quinolin-
4(1H)-one 1d
Compound 1d was prepared from 2d (95 mg, 0.3 mmol) and
ortho-tert-butylaniline 3a (90 mg, 0.6 mmol) in accordance with
the general procedure for the synthesis of 1. Purification of the res-
idue by column chromatography (hexane/AcOEt = 1) gave 1d
(53 mg, 46%). The ee (52% ee) of 1d was determined by HPLC anal-
ysis using a CHIRALPACK OD-3 column [25 ꢀ 0.46 cm i.d.; 10% i-
PrOH in hexane; flow rate, 1.5 mL/min; (ꢁ)-1d (major); tR =
16.0 min, (+)-1d (minor); tR = 26.3 min]. 1d (52% ee): white solid;
ee): white solid; ½a D
ꢂ
¼ ꢁ49:1 (c 0.40, CHCl3); mp 261–264 °C; 1H
NMR (400 MHz, CDCl3, TMS) d = 8.50 (1H, dd, J = 1.4, 8.2 Hz), 8.07
(2H, td, J = 2.2, 8.7 Hz), 7.50–7.55 (2H, m), 7.37–7.46 (4H, m),
7.26 (1H, dt, J = 1.4, 7.8 Hz), 7.13 (1H, dd, J = 1.4, 7.8 Hz), 6.78
(1H, d, J = 8.2 Hz), 6,42 (1H, s), 1.01 (9H, s); 13C NMR (100 MHz,
CDCl3, TMS) d = 177.8, 151.6, 147.7, 147.6, 143.6, 141.7, 134.7,
132.8, 132.4, 131.6, 130.9, 130.1, 127.0, 126.4, 126.1, 124.1,
122.9, 118.7, 113.2, 36.3, 31.7; IR (neat) 1625 cmꢁ1; MS (ESI, m/z)
399 (MH+); HRMS (ESI). Calcd for C25H23N2O3 (MH+) 399.1709.
Found: 399.1697.
½
a 2D5
ꢂ
¼ ꢁ42:3 (c 0.41, CHCl3); mp 173–176 °C; 1H NMR (400 MHz,
CDCl3, TMS) d = 8.50 (1H, dd, J = 1.4, 7.8 Hz), 7.45–7.51 (2H, m),
7.33–7.40 (2H, m), 7.25 (1H, dt, J = 1.4, 7.9 Hz), 7.10–7.16 (3H,
m), 6.75 (1H, d, J = 8.7 Hz), 6.70 (2H, dt, J = 2.7, 9.2 Hz), 6,46 (1H,
s), 3.74 (3H, s), 0.96 (9H, s); 13C NMR (100 MHz, CDCl3, TMS)
d = 178.1, 159.7, 154.1, 147.5, 143.7, 135.4, 133.0, 131.8, 131.4,
131.3, 129.5, 127.8, 126.6, 126.2, 125.9, 123.5, 118.7, 113.1, 55.2,
36.3, 31.5; IR (neat) 1620 cmꢁ1; MS (ESI, m/z) 384 (MH+); HRMS
(ESI). Calcd for C26H26NO2 (MH+) 384.1964. Found: 384.1963.
4.3.8. 1-(2-(tert-Butyl)phenyl)-2-(2-methoxyphenyl)quinolin-
4(1H)-one 1h
Compound 1h was prepared from 2h (95 mg, 0.3 mmol) and
ortho-tert-butylaniline 3a (90 mg, 0.6 mmol) in accordance with
the general procedure for the synthesis of 1. Purification of the res-
idue by column chromatography (hexane/AcOEt = 1) gave 1h
(51 mg, 45%). The ee (60% ee) of 1h was determined by HPLC anal-
ysis using a CHIRALPACK AD column [25 ꢀ 0.46 cm i.d.; 10% i-PrOH
in hexane; flow rate, 2.0 mL/min; (+)-1h (minor); tR = 12.5 min,
(ꢁ)-1h (major); tR = 16.1 min]. Compound 1h (60% ee): white solid;
4.3.5. 1-(2-(tert-Butyl)phenyl)-2-(4-methylphenyl)quinolin-
4(1H)-one 1e
Compound 1e was prepared from 2e (90 mg, 0.3 mmol) and
ortho-tert-butylaniline 3a (90 mg, 0.6 mmol) in accordance with
the general procedure for the synthesis of 1. Purification of the
residue by column chromatography (hexane/AcOEt = 1) gave 1e
(53 mg, 48%). The ee (54% ee) of 1e was determined by HPLC anal-
ysis using a CHIRALPACK OD-3 column [25 ꢀ 0.46 cm i.d.; 10%
i-PrOH in hexane; flow rate, 1.5 mL/min; (ꢁ)-1e (major); tR =
½
a 2D5
ꢂ
¼ þ19:4 (c 0.40, CHCl3); mp 236–238 °C; 1H NMR (400 MHz,
CDCl3, TMS) d = 8.51 (1H, dd, J = 1.8, 8.2 Hz), 7.47 (1H, ddd,